291 related articles for article (PubMed ID: 33363625)
1. Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid.
Shao J; Fang Y; Zhao R; Chen F; Yang M; Jiang J; Chen Z; Yuan X; Jia L
Asian J Pharm Sci; 2020 Nov; 15(6):685-700. PubMed ID: 33363625
[TBL] [Abstract][Full Text] [Related]
2. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.
Zhao R; Zheng G; Fan L; Shen Z; Jiang K; Guo Y; Shao JW
Acta Biomater; 2018 Apr; 70():197-210. PubMed ID: 29408311
[TBL] [Abstract][Full Text] [Related]
3. Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule.
Wang L; Yin Q; Liu C; Tang Y; Sun C; Zhuang J
Front Pharmacol; 2021; 12():706121. PubMed ID: 34295253
[No Abstract] [Full Text] [Related]
4. Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.
Chen H; Gao Y; Wang A; Zhou X; Zheng Y; Zhou J
Eur J Med Chem; 2015 Mar; 92():648-55. PubMed ID: 25617694
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Anticancer Value of the Ursolic Acid Through Nanodelivery.
Manayi A; Nikan M; Nobakht-Haghighi N; Abdollahi M
Curr Med Chem; 2018; 25(37):4866-4875. PubMed ID: 28707589
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
[TBL] [Abstract][Full Text] [Related]
7. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
8. Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies.
Zou J; Lin J; Li C; Zhao R; Fan L; Yu J; Shao J
Curr Cancer Drug Targets; 2019; 19(4):245-256. PubMed ID: 30332961
[TBL] [Abstract][Full Text] [Related]
9. Advances in production and structural derivatization of the promising molecule ursolic acid.
Liu HR; Ahmad N; Lv B; Li C
Biotechnol J; 2021 Nov; 16(11):e2000657. PubMed ID: 34096160
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential and novel formulations of ursolic acid and its derivatives: an updated review.
Namdeo P; Gidwani B; Tiwari S; Jain V; Joshi V; Shukla SS; Pandey RK; Vyas A
J Sci Food Agric; 2023 Jul; 103(9):4275-4292. PubMed ID: 36597140
[TBL] [Abstract][Full Text] [Related]
11. Ligand-free high loading capacity ursolic acid self-carried nanovesicles enable hepatocyte targeting via absorbing apolipoproteins.
Yuan C; Fan W; Zhou T; Sun D; Liu H; He Z; Wang Y
Int J Pharm; 2023 May; 638():122931. PubMed ID: 37024066
[TBL] [Abstract][Full Text] [Related]
12. A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy.
Zhang B; Jiang J; Wu P; Zou J; Le J; Lin J; Li C; Luo B; Zhang Y; Huang R; Shao J
Acta Pharm Sin B; 2021 Jan; 11(1):246-257. PubMed ID: 33532190
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid: Pharmacokinetics process in vitro and in vivo, a mini review.
Jinhua W
Arch Pharm (Weinheim); 2019 Mar; 352(3):e1800222. PubMed ID: 30663087
[TBL] [Abstract][Full Text] [Related]
14. Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (ε-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo.
Zhang H; Zheng D; Ding J; Xu H; Li X; Sun W
Int J Nanomedicine; 2015; 10():1909-20. PubMed ID: 25792825
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid: A systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model.
Sun Q; He M; Zhang M; Zeng S; Chen L; Zhou L; Xu H
Fitoterapia; 2020 Nov; 147():104735. PubMed ID: 33010369
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule Nanodrug Assembled of Dual-Anticancer Drug Conjugate for Synergetic Cancer Metastasis Therapy.
Li C; Lin J; Wu P; Zhao R; Zou J; Zhou M; Jia L; Shao J
Bioconjug Chem; 2018 Oct; 29(10):3495-3502. PubMed ID: 30252441
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Ursolic Acid-Enriched Water-Soluble and Not Cytotoxic Nanoparticles against Enterococci.
Schito AM; Caviglia D; Piatti G; Zorzoli A; Marimpietri D; Zuccari G; Schito GC; Alfei S
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834390
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy.
Wang M; Zhao T; Liu Y; Wang Q; Xing S; Li L; Wang L; Liu L; Gao D
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():1231-1240. PubMed ID: 27987679
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex.
Biswas S; Mukherjee PK; Harwansh RK; Bannerjee S; Bhattacharjee P
Drug Dev Ind Pharm; 2019 Jun; 45(6):946-958. PubMed ID: 30767678
[TBL] [Abstract][Full Text] [Related]
20. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z
Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
